HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia

European Journal of Human Genetics

Volumn 19, Issue 5, 2011, Pages 561-566

  Warby, Simon C ^a   Visscher, Henk ^a   Collins, Jennifer A ^a   Doty, Crystal N ^a   Carter, Catherine ^a   Butland, Stefanie L ^a   Hayden, Anna R ^a   Kanazawa, Ichiro ^b   Ross, Colin J ^a   Hayden, Michael R ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TOKYO   (Japan)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

CAG expansion; CAG instability; Cis elements; Haplotypes; Huntington disease; Prevalence

Indexed keywords

CIS ACTING ELEMENT; HUNTINGTIN;

ARTICLE; ASIA; CAG REPEAT; CHINA; CHROMOSOME; EUROPE; GENETIC RISK; GENOMIC INSTABILITY; HAPLOTYPE; HUNTINGTON CHOREA; JAPAN; PREVALENCE; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; HAPLOTYPES; HUMANS; HUNTINGTON DISEASE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PREVALENCE;

EID: 79955758366     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.229     Document Type: Article

References (47)

1. Walker FO: Huntington's disease. Lancet 2007; 369: 218-228. (Pubitemid 46107685)
2. Al-Jader LN, Harper PS, Krawczak M, Palmer SR: The frequency of inherited disorders database: Prevalence of Huntington disease. Community Genet 2001; 4: 148-157. (Pubitemid 34293648)
3. Andrew SE, Hayden MR: Origins and evolution of Huntington disease chromosomes. Neurodegeneration 1995; 4: 239-244.
4. Harper PS: The epidemiology of Huntington's disease. Hum Genet 1992; 89: 365-376.
5. Squitieri F, Andrew SE, Goldberg YP et al: DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Hum Mol Genet 1994; 3: 2103-2114.
6. HaydenMR: Huntington's Chorea. New York: Springer, 1981.
7. Leung CM, Chan YW, Chang CM, Yu YL, Chen CN: Huntington's disease in Chinese: A hypothesis of its origin. J Neurol Neurosurg Psychiatry 1992; 55: 681-684.
8. Chang CM, Yu YL, Fong KY et al: Huntington's disease in Hong Kong Chinese: Epidemiology and clinical picture. Clin Exp Neurol 1994; 31: 43-51.
9. Nakashima K, Watanabe Y, Kusumi M et al: Epidemiological and genetic studies of Huntington's disease in the San-in area of Japan. Neuroepidemiology 1996; 15: 126-131. (Pubitemid 26157785)
10. Masuda N, Goto J, Murayama N, Watanabe M, Kondo I, Kanazawa I: Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease. J Med Genet 1995; 32: 701-705.
11. Adachi Y, Nakashima K: Population genetic study of Huntington's disease-prevalence and founder's effect in the San-in area, western Japan. Nippon Rinsho 1999; 57: 900-904.
12. Narabayashi H: Huntington's Chorea in Japan: Review of the literature. Adv Neurol 1973; 1: 253-259.
13. De Rooij KE, Koning Gans PA, Skraastad MI et al: Dynamic mutation in Dutch Huntington's disease patients: Increased paternal repeat instability extending to within the normal size range. J Med Genet 1993; 30: 996-1002. (Pubitemid 23356867)
14. Goldberg YP, McMurray CT, Zeisler J et al: Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Hum Mol Genet 1995; 4: 1911-1918.
15. Semaka A, Creighton S, Warby S, Hayden MR: Predictive testing for Huntington disease: Interpretation and significance of intermediate alleles. Clin Genet 2006; 70: 283-294. (Pubitemid 44323391)
16. Falush D, Almqvist EW, Brinkmann RR, Iwasa Y, Hayden MR: Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. Am J Hum Genet 2001; 68: 373-385. (Pubitemid 32147807)
17. Almqvist EW, Elterman DS, MacLeod PM, Hayden MR: High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia. Clin Genet 2001; 60: 198-205. (Pubitemid 32982816)
18. Langbehn DR, Hayden MR, Paulsen JS: CAG-repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 397-408.
19. Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR: A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004; 65: 267-277. (Pubitemid 38443548)
20. Rubinsztein DC, Amos W, Leggo J et al: Mutational bias provides a model for the evolution of Huntington's disease and predicts a general increase in disease prevalence. Nat Genet 1994; 7: 525-530. (Pubitemid 24308341)
21. Warby SC, Montpetit A, Hayden AR et al: CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 2009; 84: 351-366.
22. Warby SC, Visscher H, Butland S, Pearson CE, Hayden MR: Response to Falush: A role for cis-element polymorphisms in HD. Am J Hum Genet 2009; 85: 942-945.
23. Almqvist E, Spence N, Nichol K et al: Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: Insights into the genetic evolution of Huntington disease. Hum Mol Genet 1995; 4: 207-214.
24. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989. (Pubitemid 32289743)
25. Potter NT, Spector EB, Prior TW: Technical standards and guidelines for Huntington disease testing. Genet Med 2004; 6: 61-65. (Pubitemid 38175981)
26. Soong BW, Wang JT: A study on Huntington's disease associated trinucleotide repeat within the Chinese population. Proc Natl Sci Counc Repub China B 1995; 19: 137-142.
27. Falush D: Haplotype background, repeat length evolution, and Huntington's disease. Am J Hum Genet 2009; 85: 939-942.
28. Kremer B, Almqvist E, Theilmann J et al: Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. Am J Hum Genet 1995; 57: 343-350.
29. Pearson CE, Edamura KN, Cleary JD: Repeat instability: Mechanisms of dynamic mutations. Nat Rev Genet 2005; 6: 729-742. (Pubitemid 41400831)
30. Butland SL, Devon RS, Huang Y et al: CAG-encoded polyglutamine length polymorphism in the human genome. BMC Genomics 2007; 8: 126.
31. Libby RT, Monckton DG, Fu YH et al: Genomic context drives SCA7 CAG repeat instability, while expressed SCA7 cDNAs are intergenerationally and somatically stable in transgenic mice. Hum Mol Genet 2003; 12: 41-50. (Pubitemid 36097714)
32. Libby RT, Hagerman KA, Pineda VV et al: CTCF cis-regulates trinucleotide repeat instability in an epigenetic manner: A novel basis for mutational hot spot determination. PLoS Genet 2008; 4: E1000257.
33. Gutenkunst RN, Hernandez RD, Williamson SH, Bustamante CD: Inferring the joint demographic history of multiple populations from multidimensional SNP frequency data. PLoS Genetics 2009; 5: E1000695-e1000695.
34. Garrigan D, Kingan SB, Pilkington MM et al: Inferring human population sizes, divergence times and rates of gene flow from mitochondrial, X and Y chromosome resequencing data. Genetics 2007; 177: 2195-2207. (Pubitemid 350276999)
35. Palo J, Somer H, Ikonen E, Karila L, Peltonen L: Low prevalence of Huntington's disease in Finland. Lancet 1987; 2: 805-806. (Pubitemid 17133158)
36. Mattsson B: Huntington's chorea in Sweden. Acta Psychiatrica Scandinavica Supplementum 1974; 255: 211-220.
37. Saugstad L, Odegård O: Huntington's chorea in Norway. Psychol Med 1986; 16: 39-48. (Pubitemid 16130404)
38. Paradisi I, Hernández A, Arias S: Huntington disease mutation in Venezuela: Age of onset, haplotype analyses and geographic aggregation. J Hum Genet 2008; 53: 127-135.
39. Avila-Giron R: Medical and social aspects of Huntington's chorea in the state of Zulia, Venezuela. Adv Neurol 1973; 1: 261-266.
40. Shiwach RS, Lindenbaum RH: Prevalence of Huntington's disease among UK immigrants from the Indian subcontinent. Br J Psychiatry: J Mental Sci 1990; 157: 598-599. (Pubitemid 20335974)
41. Saleem Q, Roy S, Murgood U et al: Molecular analysis of Huntington's disease and linked polymorphisms in the Indian population. Acta Neurol Scand 2003; 108: 281-286. (Pubitemid 37153535)
42. Hayden MR, Beighton P: Huntington's chorea in the Cape coloured community of South Africa. S Afr Med J 1977; 52: 886-888. (Pubitemid 8272176)
43. Hayden MR, MacGregor JM, Beighton PH: The prevalence of Huntington's chorea in South Africa. S Afr Med J 1980; 58: 193-196. (Pubitemid 10036596)
44. Scholefield J, Greenberg J: A common SNP haplotype provides molecular proof of a founder effect of Huntington disease linking two South African populations. Eur J Hum Genet 2007; 15: 590-595. (Pubitemid 46681465)
45. Siesling S, Vetger-van de Vlis M, Losekoot M et al: Family history and DNA analysis in patients with suspected Huntington's disease. J Neurol Neurosurg Psychiatry 2000; 69: 54-59. (Pubitemid 30410415)
46. Margolis RL, Rudnicki DD, Holmes SE: Huntington's disease like-2: Review and update. Acta Neurol Taiwan 2005; 14: 1-8. (Pubitemid 40515830)
47. Conneally PM: Huntington disease: Genetics and epidemiology. Am J Hum Genet 1984; 36: 506-526. (Pubitemid 14121883)